BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19223559)

  • 1. Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women.
    Trottier H; Mahmud SM; Lindsay L; Jenkins D; Quint W; Wieting SL; Schuind A; Franco EL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):854-62. PubMed ID: 19223559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.
    Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Hernandez-Avila M; Brown DR; Elbasha E; Muñoz N; Paavonen J; Haupt RM;
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):287-96. PubMed ID: 21300618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
    Ho GY; Burk RD; Klein S; Kadish AS; Chang CJ; Palan P; Basu J; Tachezy R; Lewis R; Romney S
    J Natl Cancer Inst; 1995 Sep; 87(18):1365-71. PubMed ID: 7658497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of a human papillomavirus type 16 vaccine.
    Koutsky LA; Ault KA; Wheeler CM; Brown DR; Barr E; Alvarez FB; Chiacchierini LM; Jansen KU;
    N Engl J Med; 2002 Nov; 347(21):1645-51. PubMed ID: 12444178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
    Liaw KL; Glass AG; Manos MM; Greer CE; Scott DR; Sherman M; Burk RD; Kurman RJ; Wacholder S; Rush BB; Cadell DM; Lawler P; Tabor D; Schiffman M
    J Natl Cancer Inst; 1999 Jun; 91(11):954-60. PubMed ID: 10359548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
    Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
    Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
    Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.
    Hildesheim A; Gonzalez P; Kreimer AR; Wacholder S; Schussler J; Rodriguez AC; Porras C; Schiffman M; Sidawy M; Schiller JT; Lowy DR; Herrero R;
    Am J Obstet Gynecol; 2016 Aug; 215(2):212.e1-212.e15. PubMed ID: 26892991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
    Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
    BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and duration of human papillomavirus lesions, after initial infection.
    Winer RL; Kiviat NB; Hughes JP; Adam DE; Lee SK; Kuypers JM; Koutsky LA
    J Infect Dis; 2005 Mar; 191(5):731-8. PubMed ID: 15688287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
    Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
    Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
    Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human papillomavirus associated cervix uteri morbidity in Hungary: epidemiology and correlation with the HPV types and the simultaneous cytological diagnosis].
    Szentirmay Z; Veleczki Z; Kásler M
    Orv Hetil; 2017 Aug; 158(31):1213-1221. PubMed ID: 28758434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.
    Harper DM; Franco EL; Wheeler C; Ferris DG; Jenkins D; Schuind A; Zahaf T; Innis B; Naud P; De Carvalho NS; Roteli-Martins CM; Teixeira J; Blatter MM; Korn AP; Quint W; Dubin G;
    Lancet; 2004 Nov 13-19; 364(9447):1757-65. PubMed ID: 15541448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.
    Minkoff H; Zhong Y; Strickler HD; Watts DH; Palefsky JM; Levine AM; D'Souza G; Howard AA; Plankey M; Massad LS; Burk R
    Infect Dis Obstet Gynecol; 2008; 2008():587082. PubMed ID: 18437233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.